Clinical Trial Update: GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reporting safety and pharmacological characteristics of GNR-084 in refractory or relapsed B-precursor acute lymphoblastic leukemia, span…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-precursor Acute Lymphoblastic Leukemia

Drugs mentioned

• GNR-084

Snippet

Sponsor: AO GENERIUM | Conditions: B-precursor Acute Lymphoblastic Leukemia, ALL | Phase 1, Phase 2 | Status: UNKNOWN